Our group observed high levels of XIAP expression in 16 out of 32 (50%) samples from CML patients at early chronic phase and five out of nine samples (55.5%) at advanced phases (Table 1). Here, XIAP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.